Talking Back to Prozac: The Book That Tells the Truth about Prozac, Paxil, Zoloft, Luvox, Celexa, Lexapro, Effexor, Cymbalta, Wellbutrin and More

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) July 27, 2010 -- Authors Peter R Breggin MD and Ginger Breggin have re-released their seminal book Talking Back to Prozac: What Doctors Aren’t Telling You About Prozac and the Newer Antidepressants with a new introduction and new information about the SSRI antidepressants, including the granddaddy of them all—Prozac.

This is the Breggin book that blew the whistle on the skewed science of the “new” antidepressants, including Paxil, Prozac, Luvox, Zoloft, Celexa, Lexapro, Effexor, Cymbalta and Wellbutrin.

Here follows a portion of the new introduction to Talking Back to Prozac:

“How good is the science in this book? How valid and convincing is it—even to the drug companies that I am criticizing? I have now been a medical expert in dozens of product liability suits against pharmaceutical companies, including the manufacturers of drugs examined in this book: Prozac, Paxil and Zoloft. Most of the lawsuits have centered on the main issues in this book: antidepressant-induced violence, suicide and mania. In most of these cases, the plaintiffs or the plaintiffs’ families have hired me after individuals have committed suicide, perpetrated crimes, or otherwise ruined their lives while under the influence of an antidepressant.

”Most of the antidepressant cases in which I have been an expert have been settled to the satisfaction of the people who brought the suit against the drug company. Sometimes the drug companies have given a million, or even many millions of dollars, to the plaintiffs—of course, always without admitting guilt. Except for one case that was settled for millions of dollars during the trial2, in no case has an antidepressant manufacturer chosen to go to court in a case in which I have been a medical expert. The reason, I believe, is that the science I have presented is solid and even incontrovertible. The drug companies don’t want the evidence coming out in open court and they don’t want to risk losing a high-profile case.

”As a result of my work as a medical expert against the drug companies, teams of opposing lawyers and opposing medical experts have scrutinized my medical opinions and this book in particular. This high-powered critical assault has been going on for years and it has turned up no errors in this book. None of the original book needs correction. It would be difficult to exaggerate how much financial investment and manpower the drug companies have devoted to examining Talking Back to Prozac without finding any scientific or factual errors.

”In addition to its unsullied record as a scientific work, Talking Back to Prozac remains worthwhile reading as a demonstration that objective analyses—i.e., analyses done by a scientist independent of the Psychopharmaceutical Complex—can come to clear conclusions years ahead of the medical establishment with its ties to the drug companies.
Talking Back to Prozac continues to provide a model for how to go about examining the actual adverse effects and efficacy of psychiatric drugs, or the risk/benefit ratio. The rich detail in this book remains relevant and useful to a variety of researchers as well as to medical experts and attorneys involved in product liability litigation against pharmaceutical companies.

”If you were to read this book by itself, you would know more about the risks of the newer antidepressants than most physicians.

”This introduction examines the evolution of the drug labels for SSRI antidepressants including Prozac, Paxil and Zoloft. The evolution of the drug label allows an in-depth look at the FDA’s acknowledged hazards of the newer antidepressants.

”My most recent book, Medication Madness: A Psychiatrist Exposes the Dangers of Mood-Altering Drugs (2008), presents dozens of new cases of individuals driven to take out-of-character and sometimes horrendously destructive actions while under the influence of the newer antidepressants. It introduces the concept of medication spellbinding which helps to explain how people fail to appreciate the negative emotional and psychological effects of psychoactive agents while they are taking them; how they can feel better than ever when they are in reality doing worse than ever; and how they will sometimes commit harmful actions that they would never have perpetrated except for the spellbinding drug effect.

Learn more at http://www.breggin.com.
Read the whole story in this timely and fascinating examination of both the science and the politics of Big Pharma and the psychiatric industry—what Dr. Peter Breggin calls the Psychopharmaceutical Complex. For information about Dr. Breggin's reform organization see his website: http://www.empathictherapy.org or http://www.icspp.info.

Peter R Breggin     ssri antidepressants     violence and suicide risk